The news agency Asian News International (ANI) on Friday (September 6, 2024) issued a rebuke to the Wikimedia Foundation on the latter’s statement responding to the Delhi High Court verbally ...
DD-04107 is under clinical development by BCN Peptides and currently in Phase III for Pruritus. According to GlobalData, Phase III drugs for Pruritus have a 60% phase transition success rate (PTSR) ...